129 related articles for article (PubMed ID: 22640907)
1. Magnetic nanovectors for drug delivery.
Klostergaard J; Seeney CE
Nanomedicine; 2012 Sep; 8 Suppl 1():S37-50. PubMed ID: 22640907
[TBL] [Abstract][Full Text] [Related]
2. Magnetic nanovectors for drug delivery.
Klostergaard J; Seeney CE
Maturitas; 2012 Sep; 73(1):33-44. PubMed ID: 22402027
[TBL] [Abstract][Full Text] [Related]
3. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles for cancer therapy using magnetic forces.
Tietze R; Lyer S; Dürr S; Alexiou C
Nanomedicine (Lond); 2012 Mar; 7(3):447-57. PubMed ID: 22385201
[TBL] [Abstract][Full Text] [Related]
5. Magnetically vectored platforms for the targeted delivery of therapeutics to tumors: history and current status.
Seeney C; Ojwang JO; Weiss RD; Klostergaard J
Nanomedicine (Lond); 2012 Feb; 7(2):289-99. PubMed ID: 22339137
[TBL] [Abstract][Full Text] [Related]
6. [Magnetically based enhancement of nanoparticle uptake in tumor cells: combination of magnetically induced cell labeling and magnetic heating].
Kettering M; Winter J; Zeisberger M; Alexiou C; Bremer-Streck S; Bergemann C; Kaiser WA; Hilger I
Rofo; 2006 Dec; 178(12):1255-60. PubMed ID: 17136650
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine for cancer: lipid-based nanostructures for drug delivery and monitoring.
Namiki Y; Fuchigami T; Tada N; Kawamura R; Matsunuma S; Kitamoto Y; Nakagawa M
Acc Chem Res; 2011 Oct; 44(10):1080-93. PubMed ID: 21786832
[TBL] [Abstract][Full Text] [Related]
8. PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect.
Acharya S; Sahoo SK
Adv Drug Deliv Rev; 2011 Mar; 63(3):170-83. PubMed ID: 20965219
[TBL] [Abstract][Full Text] [Related]
9. Magnetically targeted nanoparticles for brain tumor therapy: what does the future hold?
David AE; Cole AJ; Yang VC
Nanomedicine (Lond); 2011 Sep; 6(7):1133-5. PubMed ID: 21929450
[No Abstract] [Full Text] [Related]
10. Emerging nanomedicines for early cancer detection and improved treatment: current perspective and future promise.
Bharali DJ; Mousa SA
Pharmacol Ther; 2010 Nov; 128(2):324-35. PubMed ID: 20705093
[TBL] [Abstract][Full Text] [Related]
11. A magnetically guided anti-cancer drug delivery system using porous FePt capsules.
Fuchigami T; Kawamura R; Kitamoto Y; Nakagawa M; Namiki Y
Biomaterials; 2012 Feb; 33(5):1682-7. PubMed ID: 22123601
[TBL] [Abstract][Full Text] [Related]
12. Nanoparticles for delivery of chemotherapeutic agents to tumors.
Vijayaraghavalu S; Raghavan D; Labhasetwar V
Curr Opin Investig Drugs; 2007 Jun; 8(6):477-84. PubMed ID: 17621878
[TBL] [Abstract][Full Text] [Related]
13. Surface-functionalized ultrasmall superparamagnetic nanoparticles as magnetic delivery vectors for camptothecin.
Cengelli F; Grzyb JA; Montoro A; Hofmann H; Hanessian S; Juillerat-Jeanneret L
ChemMedChem; 2009 Jun; 4(6):988-97. PubMed ID: 19347834
[TBL] [Abstract][Full Text] [Related]
14. Self-aggregated pegylated poly (trimethylene carbonate) nanoparticles decorated with c(RGDyK) peptide for targeted paclitaxel delivery to integrin-rich tumors.
Jiang X; Sha X; Xin H; Chen L; Gao X; Wang X; Law K; Gu J; Chen Y; Jiang Y; Ren X; Ren Q; Fang X
Biomaterials; 2011 Dec; 32(35):9457-69. PubMed ID: 21911250
[TBL] [Abstract][Full Text] [Related]
15. Magnetic nanoparticles: an update of application for drug delivery and possible toxic effects.
Kim JE; Shin JY; Cho MH
Arch Toxicol; 2012 May; 86(5):685-700. PubMed ID: 22076106
[TBL] [Abstract][Full Text] [Related]
16. Nanoparticle delivery for metastatic breast cancer.
Grobmyer SR; Zhou G; Gutwein LG; Iwakuma N; Sharma P; Hochwald SN
Nanomedicine; 2012 Sep; 8 Suppl 1():S21-30. PubMed ID: 22640908
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, in vitro and in vivo evaluation of radiolabeled nanoparticles.
Shokeen M; Fettig NM; Rossin R
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):267-77. PubMed ID: 18475250
[TBL] [Abstract][Full Text] [Related]
18. Nanoparticle and targeted systems for cancer therapy.
Brannon-Peppas L; Blanchette JO
Adv Drug Deliv Rev; 2004 Sep; 56(11):1649-59. PubMed ID: 15350294
[TBL] [Abstract][Full Text] [Related]
19. Better safe than sorry: Understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications.
Fadeel B; Garcia-Bennett AE
Adv Drug Deliv Rev; 2010 Mar; 62(3):362-74. PubMed ID: 19900497
[TBL] [Abstract][Full Text] [Related]
20. Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery.
Arsianti M; Lim M; Marquis CP; Amal R
Langmuir; 2010 May; 26(10):7314-26. PubMed ID: 20112951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
